All company news and stories
Just as every handwritten signature is unique, so is every cancerous tumor. Researchers at the Technion-Israel Institute of Technology have now used artificial intelligence and big datato decode the unique signatures of certain cancer cells.
Chemical analysis of blood samples, combined with an artificial intelligence program, could speed up the diagnosis of brain tumors, according to research presented at the 2019 NCRI Cancer Conference.
In the earliest days of medicine, people needed a trip to the doctor like a hole in the head. Because that’s exactly what they got: Healers and witch doctors were downright wanton in their use of trepanning — the practice of sharpening a stone to cut away a section of skull in fully conscious patients. Trepanning was done to relieve headaches, remove fractured skull fragments, provide spirits with an easy entrance or escape, sometimes just to provide rondelles — the leftover bony disks valued as charms or talismans.
Yogi Berra was right when he said, “The future ain’t what it used to be.” Only he wasn’t right in the way he meant it, which was usually the case. The future really isn’t what it used to be — it’s much, much brighter.
Hospital bedsheets and patient gowns are a major conduit for transferring dangerous bacteria estimated to infect 1.7 million hospitalized Americans and 3.5 million hospitalized Europeans every year. In the United States, hospital-acquired infections kill about 98,000 people yearly.
Ewing’s sarcoma is a very rare type of cancerous tumor that got its name from Dr. James Ewing, the physician who first described it almost exactly a century ago. It affects children through young adults – mostly teens – and can appear anywhere in the body, but it usually originates in the long bones of the arms and legs, the pelvis or the chest.
A new study led by Israeli researchers has found evidence that there could be damage to the brain’s protective barrier even without a reported concussion.
Sheba Medical Center, Tel HaShomer, in collaboration with Telesofia Medical, has announced the launch of a new, personalized telemedicine program that will enable cancer patients to quickly reach their doctors and get personalized feedback via video within the comfort of their own homes.
Sight Diagnostics’ new device gives results of a standard blood count test in just 10 minutes, without lab processing.
